Biotechnology
World Pharmaceutical and Biopharmaceutical Market
2010-2015 (Pipeline Analysis of the Top 50
Companies)
This report is
the result of a detailed analysis of the late stage R&D pipeline of the
50 top companies in pharmaceuticals, the companies that produce the
lion's share of revenues. While the report looks at the entire pipeline
to 2015, a key focus of the report is the increasing role of
biopharmaceutical products. The growing interest in biotechnology
development has transitioned the pharmaceutical industry to
biopharmaceuticals in less than a decade. August 2010
Top 10 Biotech Companies. Market Outlook, 2008-2023
The global biotech drug market was worth over $75bn in 2007, with
double-figure growth noticeably higher that that of the overall
pharmaceutical market. This report will help you to understand those
developments and their significance. That report provides valuable
commercial information on this exciting industry that no healthcare
company should ignore.
read more ...
Biomarkers: The Future of Next-Generation Drug R&D
This report analyzes the hot global market for biomarkers and related
assays or tests used in drug R&D. The study reviews this dynamic market
by looking at drug research and development spending trends, M&As,
alliances, major diseases, applications, tools, technologies, products
and services. This report suggests the future direction of the market
for biomarkers and related '-omic' or pharmacogenomic (PGx) assays or
tests used in the next-generation of drug R&D. This study sizes the
world market and growth rate of biomarkers and assays for drug R&D
spending to 2012.
Read more ...
RNA interference
markets
Since its discovery, the naturally occurring RNA (ribonucleic acid)
interference effect has been acclaimed as the most exciting technical
breakthrough in biological research in the last decade. Some industry
analysts predict that RNA interference (RNAi) may even surpass PCR as a
top technology. Read more
...
Report: Molecular Diagnostics.
Technologies, Markets and Companies
This best-selling report describes and evaluates the molecular
diagnostics technologies that will play an important role in practice of
medicine, public health, pharmaceutical industry, forensics and
biological warfare in the 21st century. Aimed at chief executives and
chief development officers, it is the most comprehensive and up-to-date
one-stop source of information on technical and commercial aspects of
molecular diagnostics. It includes profiles of 250 companies
more ...
To top
|
|
|